Physician profile
Patrick J Nelson
NPI 1902193618
$27,697.07
in general payments reported to CMS, 2019-2025
22 companies · $3,122 in 2025
The $3,122 reported for 2025 was more than what 90% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,288 · 2020: $1,293 · 2021: $4,969 · 2022: $3,516 · 2023: $6,841 · 2024: $5,668 · 2025: $3,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $5,332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,298.89 |
| Travel and Lodging | $5,331.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $24,236.01 | 2019-2025 | Ortholoc 2 Lapifuse, Viaflow, Inbone |
| Smith+Nephew, INC. | $2,234.43 | 2019-2025 | Grafix Pl, Collagenase Santyl, Stravix |
| Abbott Laboratories | $172.93 | 2021 | |
| Horizon Therapeutics Plc | $164.09 | 2019-2021 | |
| Osiris Therapeutics INC. | $140.37 | 2019 | |
| Kerecis Limited | $87.97 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $74.48 | 2020-2025 | Apligraf |
| Innovation Technologies INC | $72.80 | 2019-2024 | Irrisept |
| Integra Lifesciences Corporation | $72.65 | 2022 | |
| Orpyx Medical Technologies US INC. | $53.38 | 2023 | Orpyx Si |
| Treace Medical Concepts, INC. | $52.86 | 2022-2024 | |
| Grt US Holding, INC. | $45.36 | 2021-2022 | |
| Averitas Pharma INC. | $44.31 | 2023-2024 | Qutenza |
| Misonix INC | $43.37 | 2020 | |
| Nevro Corp. | $40.44 | 2022-2023 | Senza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $35.17 | 2021-2024 | Nuzyra |
| Becton, Dickinson and Company | $32.27 | 2025 | Surgiphor |
| Orthofix Medical, INC. | $27.63 | 2019-2025 | Accelstim |
| Conetic Solutions, INC. | $20.32 | 2022 | |
| Ethicon US, LLC | $17.55 | 2019 | |
| Heron Therapeutics, INC. | $15.06 | 2023 | Zynrelef |
| Zimmer Biomet Holdings, INC. | $13.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.